Tag: Vaccine

Categories
Politics

Biden Administration Proclaims Advert Marketing campaign to Fight Vaccine Hesitancy

Biden Administration Announces Ad Campaign to Combat Vaccine Hesitancy

WASHINGTON – The Biden government announced Thursday morning an ambitious publicity campaign to encourage as many Americans as possible to get vaccinated against the coronavirus.

The campaign, with advertisements in English and Spanish that will air on network television and cable channels across the country and online throughout April, comes as the administration rapidly expands access to coronavirus vaccines.

President Biden announced a new goal last week of giving 200 million doses by his 100th day in office, doubling his original goal of 100 million bullets in the arms of Americans when he was in office. And last month, in an address to the nation, he announced a goal of vaccine qualification for all adults in the United States by May 1. Governors and public health officials in more than 40 states have said they will meet or exceed this deadline.

However, deep skepticism about the vaccine remains a problem, especially among blacks, Latinos, Republicans, and white evangelicals. Administration officials believe that if many Americans continue to refuse to be vaccinated, supply will soon exceed demand. And widespread resistance to vaccinations could hinder returns to more normal lifestyles as the virus continues to spread.

Two hundred and seventy-five organizations will participate in the government’s new public awareness boost – including NASCAR, the Catholic Health Association of the United States, and the North American Meat Institute – aimed at communities where vaccine reluctance remains high. Organizations include many Catholic and Evangelical groups that are expected to help address religious concerns about the Johnson & Johnson vaccine, which uses abortion-derived fetal cell lines.

The group is collectively known as the Covid-19 Community Corps, administrative officials said, and the participating organizations can reach millions of Americans who trust these individual groups.

A new survey by the Kaiser Family Foundation this week found that the number of black adults ready to be vaccinated has increased significantly since February. Overall, 13 percent of respondents said they would “definitely not” receive a vaccine. Among Republicans and White Evangelical Christians, nearly 30 percent of each group said they would “definitely not” get a shot.

Updated

April 1, 2021, 7:26 a.m. ET

Government officials said their research showed that vaccine news from medical professionals and community leaders, rather than celebrities or the president, was often more convincing.

“We’re not always the best messengers,” White House press secretary Jen Psaki said last month when speaking about the hesitation of the vaccine among conservatives.

The full list of participating organizations includes health professionals, scientists, community organizations, religious leaders, corporations, rural interest groups, civil rights organizations, sports leagues, and athletes. The Department of Health and Human Services is also helping to educate people about vaccines by posting “Let’s Get Vacceted” frames for Facebook users to add to their profile photos.

Part of the challenge of convincing skeptical Americans is the personal and varied reasons behind the vaccine’s hesitation.

“I have a couple of bags that cite religious reasons for the Johnson & Johnson vaccine,” said Shirley Bloomfield, executive director of NTCA – The Rural Broadband Association, which told the White House what she heard from members of her group . “There are a lot of pockets that people have already had Covid in and feel like, ‘Well, we’ve all got it, so we’re not really under pressure.'”

The tone of the ads is hopeful and is intended as a call to action. Everyone can help end the pandemic by getting vaccinated.

To further emphasize this point, the Department of Health and Human Services has separately purchased a multimillion-dollar advertisement in black and Spanish language media and outlets reaching Asian-American and tribal communities to reaffirm the message about safety and effectiveness of coronavirus vaccines.

The government announced last week that it is allocating nearly $ 10 billion to improve access to vaccines and confidence in minority communities hardest hit by the pandemic.

Biden officials have worked with many of the groups involved in the Covid-19 Community Corps since the presidential change, but the formal launch of an advertising campaign had to wait until vaccine supplies were at a level where people could be quick to those provided to them Information reacts.

Categories
World News

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Manufacturing facility Combine-Up

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up

Workers at a Baltimore plant that made two coronavirus vaccines accidentally merged the ingredients a few weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay approving the plant’s production lines.

The facility is operated by Emergent BioSolutions, a manufacturing partner of Johnson & Johnson and AstraZeneca, the Anglo-Swedish company whose vaccine is not yet approved for use in the United States. Federal officials attributed the error to human error.

The mix-up has delayed future shipments of Johnson & Johnson cans in the U.S. while the Food and Drug Administration investigates what happened. Johnson & Johnson has strengthened its control over the work of Emergent BioSolutions to avoid additional quality defects.

The mistake is a major embarrassment for both Johnson & Johnson, whose single-dose vaccine is credited with accelerating the national vaccination program, and Emergent, its subcontractor, who has received heavy criticism for its strong lobbying for federal contracts, particularly for the emergency Government Health Stock.

The bug does not affect any Johnson & Johnson cans currently shipped and used nationwide, including shipments that states are anticipating next week. All of these cans were made in the Netherlands, where the operations were fully approved by federal regulators.

More shipments of the Johnson & Johnson vaccine – expected to be 24 million doses next month – should come from the huge Baltimore facility. These supplies are now in question while quality control issues are being resolved according to those familiar with the matter.

Federal officials are still expecting enough doses from Johnson & Johnson and the other two approved coronavirus vaccine manufacturers to meet President Biden’s commitment to provide enough vaccines to immunize every adult by the end of May.

Pfizer is shipping its doses ahead of schedule, and Moderna is about to approve the supply of vaccine bottles of up to 15 doses instead of 10, further strengthening the country’s inventory.

The problems arose at a new facility the federal government hired last year to manufacture vaccines from Johnson & Johnson and AstraZeneca. The two vaccines use the same technology, which uses a harmless version of a virus – known as a vector – that is transferred into cells to make a protein, which then stimulates the immune system to produce antibodies. However, the Johnson and Johnson and AstraZeneca vectors are biologically different and not interchangeable.

At the end of February, one or more employees somehow mixed up the two during the production process and raised questions about training and supervision.

Vaccine manufacturing is a notoriously capricious science, and errors are often expected to occur and ruin batches. However, Emergent’s mistake went undetected for days until Johnson & Johnson quality controls discovered it, according to people familiar with the situation. By then, up to 15 million cans were contaminated, people said.

None of the cans ever left the plant and the lot has been quarantined.

Johnson & Johnson reported the mishap to federal regulators, who opened an investigation that delayed approval of the plant’s production lines. The company has increased the number of its own employees overseeing Emergent’s work and has introduced a number of new controls to protect against future errors.

Johnson & Johnson was already grappling with a manufacturing delay that caused the company to fail to meet its obligations to the federal government, but it appeared to be on track to catching up. 20 million doses had been administered by the end of March, and promises were made to deliver around 75 million additional doses by the end of May.

White House officials backed up their predictions in a phone call with governors on Tuesday. They forecast certain shipments from Pfizer and Moderna, but warned that Johnson & Johnson shipments would fluctuate.

In a statement late Wednesday, the company said it expected the steps it is now taking with Emergent would allow it to drop 24 million doses by the end of April, or whatever the federal government expects. However, this depends on Johnson & Johnson’s compliance with the Food and Drug Administration regulations.

Categories
Health

Covid-19 Vaccine Card Information: Maintaining it Protected, Journey, Data, Passport and Advantages

Covid-19 Vaccine Card Guide: Keeping it Safe, Travel, Information, Passport and Benefits

“Customers were looking for ways to protect their Covid-19 vaccine cards knowing they were likely to be important in the future,” said Craig Grayson, vice president of printing and marketing services at Staples, in an email on Wednesday. “Leveraging our existing in-store functionality seemed like a natural way to provide a free solution.”

Until July 25th, customers can have their finished vaccination cards laminated free of charge in Office Depot and OfficeMax branches across the country under the code 52516714.

Dr. Ikediobi also recommends keeping the card in a safe place like your passport instead of carrying it around with you. “It doesn’t always have to be with you,” she said.

In some cases, yes. Some destinations and cruise lines require travelers to be fully vaccinated prior to travel. Starting March 26, Americans who are fully vaccinated and able to show proof of vaccination will be able to visit Iceland and avoid border measures such as testing and quarantine, according to the country’s government.

The Royal Caribbean cruise line requires passengers and crew 18+ to be vaccinated to board their ships, as do Virgin Voyages, Crystal Cruises, and others. These companies will resume cruise operations in the spring and summer. Neither company has been operating cruises in United States ports to date, as the CDC has not yet given them the guidelines to follow.

Currently, airlines do not require vaccinations to travel. But the idea has been talked about a lot in the industry. In an interview with NBC Nightly News, Ed Bastian, Delta Air Lines’ chief executive officer, said that proof of vaccination will likely be required on international flights. However, it is unclear whether this is a paper certificate or a digital vaccination record.

Governor Andrew Cuomo last week announced the launch of Excelsior Pass, a free app that companies can use to scan a code to confirm whether someone has been vaccinated or tested negative for the coronavirus. To enroll, New York residents should visit the Excelsior Pass website, where they will be asked to enter their name, date of birth, and zip code. A passport – a QR code that companies can scan – is automatically generated using data from government vaccination records or test laboratory data.

Categories
Politics

Manufacturing facility Combine-Up Ruins As much as 15 Million Vaccine Doses From Johnson & Johnson

Factory Mix-Up Ruins Up to 15 Million Vaccine Doses From Johnson & Johnson

WASHINGTON – Workers at a Baltimore plant that made two coronavirus vaccines accidentally merged the ingredients a few weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay approving the plant’s production lines .

The facility is operated by Emergent BioSolutions, a manufacturing partner of Johnson & Johnson and AstraZeneca, the Anglo-Swedish company whose vaccine is not yet approved for use in the United States. Federal officials attributed the error to human error.

The mix-up has delayed future shipments of Johnson & Johnson cans in the U.S. while the Food and Drug Administration investigates what happened. Johnson & Johnson has strengthened its control over the work of Emergent BioSolutions to avoid additional quality defects.

The mistake is a major embarrassment for both Johnson & Johnson, whose single-dose vaccine is credited with accelerating the national vaccination program, and Emergent, its subcontractor, who has received heavy criticism for its strong lobbying for federal contracts, particularly for the emergency Government Health Stock.

The bug does not affect any Johnson & Johnson cans currently shipped and used nationwide, including shipments that states are anticipating next week. All of these cans were made in the Netherlands, where the operations were fully approved by federal regulators.

More shipments of the Johnson & Johnson vaccine – expected to be 24 million doses next month – should come from the huge Baltimore facility. These supplies are now in question while quality control issues are being resolved according to those familiar with the matter.

Federal officials are still expecting enough doses from Johnson & Johnson and the other two approved coronavirus vaccine manufacturers to meet President Biden’s commitment to provide enough vaccines to immunize every adult by the end of May.

Pfizer is shipping its doses ahead of schedule, and Moderna is about to approve the supply of vaccine bottles of up to 15 doses instead of 10, further strengthening the country’s inventory.

The problems arose at a new facility the federal government hired last year to manufacture vaccines from Johnson & Johnson and AstraZeneca. The two vaccines use the same technology, which uses a harmless version of a virus – known as a vector – that is transferred into cells to make a protein, which then stimulates the immune system to produce antibodies. However, the Johnson and Johnson and AstraZeneca vectors are biologically different and not interchangeable.

At the end of February, one or more employees somehow mixed up the two during the production process and raised questions about training and supervision. Over the past year, Emergent hired and trained hundreds of new employees to make millions of doses of both vaccines that should be ready by the time clinical trials showed that the vaccines were actually working.

Updated

March 31, 2021, 9:32 p.m. ET

Vaccine manufacturing is a notoriously capricious science, and errors are often expected to occur and ruin batches. However, Emergent’s mistake went undetected for days until Johnson & Johnson quality controls discovered it, according to people familiar with the situation. By then, up to 15 million cans were contaminated, people said.

None of the cans ever left the plant and the lot has been quarantined. There is no evidence that production of the AstraZeneca vaccine, which has not yet been approved by the Food and Drug Administration for emergency use, was affected.

Johnson & Johnson reported the mishap to federal regulators, who opened an investigation that delayed approval of the plant’s production lines. The company has increased the number of its own employees overseeing Emergent’s work and has introduced a number of new controls to protect against future errors.

Johnson & Johnson was already grappling with a manufacturing delay that caused the company to fail to meet its obligations to the federal government, but it appeared to be on track to catching up. 20 million doses had been administered by the end of March, and promises were made to dispense approximately another 75 million doses by the end of May.

White House officials backed up their predictions in a phone call with governors on Tuesday. They forecast certain shipments from Pfizer and Moderna, but warned that Johnson & Johnson shipments would fluctuate.

In a statement late Wednesday, the company said it expected the steps it is now taking with Emergent would allow it to drop 24 million doses by the end of April, or whatever the federal government expects. However, this depends on Johnson & Johnson’s compliance with the Food and Drug Administration regulations.

The agency last week cleared a bottling facility that Johnson & Johnson in Indiana is using to release more cans made in the Netherlands. However, this facility cannot ship cans made at the Emergent facility until the Food and Drug Administration approves it.

According to the Centers for Disease Control and Prevention, nearly seven million doses of the vaccine have been given to date, about half of which have been given.

Categories
Health

The Pfizer-BioNTech Vaccine Is Stated to Be Powerfully Protecting in Adolescents

The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents

The Pfizer BioNTech coronavirus vaccine is extremely effective in adolescents ages 12 to 15, perhaps even more effective than it is in adults, the companies reported on Wednesday. No symptomatic infections were found in children who received the vaccine in a recent clinical study. The children showed strong antibody reactions and did not show any serious side effects.

The results, if persistent, could accelerate the return to normal for millions of American families. Depending on government approval, vaccinations for middle school, high school and elementary school children might start not long before the start of the next school year.

The companies announced the results in a press release that did not include detailed data from the study that had not yet been peer-reviewed or published in a scientific journal. Still, the news was praised and excited by experts.

“Oh my god, I’m so happy to see this – it’s amazing,” said Akiko Iwasaki, an immunologist at Yale University. If the vaccine performance was A-plus in adults, the results in children were A-plus-plus.

The good news comes even if the country sees a renewed surge in infections and health officials again urge Americans to follow precautions and get vaccinated. On Monday, Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said rising cases left her feeling of “impending doom” while President Biden urged state and local officials to reinstate mask mandates.

Vaccination efforts are accelerating across the country. By Tuesday, 29 percent of Americans had received at least one dose of a coronavirus vaccine, and 16 percent had been fully vaccinated, according to the CDC

But the country cannot hope to achieve herd immunity – the point where immunity becomes so widespread that the coronavirus is slowing its passage through the population – without vaccinating the youngest Americans as well, some experts say. Children under the age of 18 make up approximately 23 percent of the population in the United States.

“The sooner we can get vaccines against as many people as possible, regardless of their age, the sooner we will feel like we are ending this pandemic for good,” said Angela Rasmussen, a virologist at Georgetown University in Washington.

Data from Israel suggest that vaccination in adults alone can significantly reduce the number of cases. “However, in order to reach the herd immunity threshold in the long term, we need to vaccinate children,” she said.

The study included 2,260 adolescents aged 12 to 15 years. The children received two doses of the vaccine three weeks apart – the same amounts and the same schedule as for adults – or a placebo with salt water.

The researchers registered 18 cases of symptomatic coronavirus infection in the placebo group and none among the children who received the vaccine. However, the low number of infections makes it difficult to accurately determine the effectiveness of the vaccine in the general population, said Dr. Rasmussen.

“But obviously it looks good for the vaccine if there are no Covid cases among the vaccinated people,” she added.

The adolescents who received the vaccine produced, on average, many more antibodies than those aged 16-25 in a previous study. The children experienced the same minor side effects as older participants, although the companies refused to be more specific.

Updated

March 31, 2021, 9:45 a.m. ET

Dr. Iwasaki said she expected antibody levels in teenagers to be comparable to those in young adults. “But they get even better readings from the vaccines,” she said. “That is really unbelievable.”

She and other experts warned that the vaccine may be less effective in children and adults against some of the variants that have come into circulation in the United States.

Pfizer and BioNTech started a clinical trial of the vaccine in children under the age of 12 just last week, and started vaccinating children ages 5 to 11. Scientists at the company plan to test the vaccine in even younger children ages 2 to 5 next week, followed by trials in children ages 6 months to 2 years.

Results from this three-phase study are expected in the second half of the year, and the companies hope to make the vaccine available to children under the age of 12 early next year.

“We share the urgency to expand the use of our vaccine to wider populations and are encouraged by data from clinical trials in adolescents 12-15 years of age,” said Albert Bourla, Pfizer chairman and CEO, in a statement.

Moderna has also tested its vaccine in children. Results of a study in adolescents aged 12 to 17 years are expected in the next few weeks and in children aged 6 months to 12 years in the second half of this year.

AstraZeneca started testing its vaccine in children 6 months and older last month, and Johnson & Johnson has announced that it will wait for the results of studies in older children before testing the vaccine in children under the age of 12.

Some parents have stated that they are reluctant to immunize their children because the risk of the virus is low. Children account for less than 1 percent of deaths from Covid-19, but about 2 percent of children with the disease require hospital care.

The new results may not affect all of these parents, but they can reassure parents who have been wary of vaccines, said Jennifer Nuzzo, an epidemiologist at the Johns Hopkins Center for Health Security.

“While I don’t think we have to wait for the children to be vaccinated to fully reopen schools, the ability to vaccinate children can help some families feel more secure when they return to school,” said they.

Pfizer and BioNTech plan to apply to the Food and Drug Administration for an emergency approval change for their vaccine in hopes of starting vaccinating older children before the start of the next school year. The companies also plan to submit their data for review and publication in a scientific journal.

You will monitor participants for two years after the second dose to assess the long-term safety and effectiveness of the vaccine. Vaccine side effects usually appear within the first six weeks, said Dr. Kristin Oliver, pediatrician and vaccine expert at Mount Sinai Hospital in New York. “Even so, it is good to know that security surveillance is continuing,” she said.

The CDC recommends that people do not receive any other vaccines for two weeks before and after receiving the two doses of the coronavirus vaccine.

But kids are getting more vaccines than ever before in the few weeks leading up to the school year, according to Dr. Oliver. Therefore, pediatricians and parents should try to get these other vaccinations earlier than usual.

The coronavirus vaccines should ideally be given by pediatricians with extensive experience immunizing children, added Dr. Oliver added. “Now is the time to plan how this rollout will take place in this age group,” she said.

Categories
Health

Extra Looking forward to Covid Vaccine however Skeptics Stay, U.S. Ballot Says

More Eager for Covid Vaccine but Skeptics Remain, U.S. Poll Says

As eligibility to get the Covid-19 vaccination rapidly expanded to all adults in many states over the next month, a new survey shows that the number of Americans, especially black adults, who want to be vaccinated continues to grow. However, it has also been found that skepticism about vaccines persists, especially among Republicans and white Evangelical Christians, an issue that the Biden government has identified as an obstacle to achieving herd immunity and returning to normal life.

According to the latest monthly survey by the Kaiser Family Foundation, around 61 percent of adults have either received their first dose or are excited about one, up from 47 percent in January.

The shift was most noticeable among black Americans, some of whom were hesitant before but also had access problems. Since February, 14 percent more black adults said they wanted or had already received the vaccine. Overall, black adults, who have also received violent advertising campaigns from celebrities, local black doctors, clergy and public health officials, now want the vaccine in numbers almost comparable to other leading populations: 55 percent compared with 61 percent for Latinos and 64 percent for whites.

The Biden government has made justice a focus of its pandemic response, adding mass vaccination centers in several underserved communities. In early March, a New York Times analysis of state-reported race and ethnicity information found that vaccination rates for blacks in the United States were half that for whites and the gap was even greater for Hispanic Americans.

Dr. Reed Tuckson, founder of the Black Coalition Against Covid, welcomed the rising adoption rates but noted that practical issues still stand in the way of inclusion.

“The data and our anecdotal feedback encourage and support the need for equitable distribution and easily accessible vaccination sites run by trustworthy organizations,” he said. “The system has to support these decisions by doing the right thing to do the simple thing.”

Overall, the survey showed that the so-called waiting group – people who have not yet made a decision – is shrinking accordingly, now at 17 percent compared to 31 percent in January. The seven-day average of vaccines administered hit 2.77 million on Tuesday, an increase from the pace of the previous week. This is based on data reported by the Centers for Disease Control and Prevention.

The survey was conducted March 15-22 among a random sample of 1,862 adults.

Despite the progress, one in five adults (20 percent) said they would either definitely refuse the shot or would only be vaccinated if necessary for their job or school. A number of employers and institutions are considering making such a requirement. Last week, Rutgers University became the first major academic institution to require students to receive the vaccine this fall (with exceptions for medical or religious reasons).

The people most likely to speak out against vaccination identify themselves as Republicans (29 percent) or white Evangelical Christians (28 percent). In contrast, only 10 percent of black adults said they definitely wouldn’t get it.

According to the Kaiser poll and other polls, Republicans have changed little in their views on vaccine acceptance in recent months, despite being more open last fall, ahead of the November presidential election. The party-political divide between the Covid-19 shots is wide. Only 46 percent of Republicans say they received or intended to receive at least one shot, compared to 79 percent of Democrats.

No group is monolithic in their reasons for rejecting or accepting the vaccines. Those who are skeptical say they generally distrust the government and are concerned about the speed of vaccine development. Much of the online misinformation clings to a fast-spreading myth – that tracker microchips are embedded in the recordings.

For rural residents, access to the vaccine is so problematic that they simply don’t see the logistics and travel time involved as worth it.

With so many reasons cited for avoiding the vaccine, it can be difficult to get messages across to improve vaccine confidence. However, the most recent Kaiser report identified a few approaches that appear to be successful in getting people to think about the shots.

At least two-thirds of the so-called wait-and-see group said they would be convinced by the message that the vaccines are “almost 100 percent effective in preventing hospital stays and the death of Covid-19”. Other strong messages included information that the new vaccines are based on 20 year old technology, that the vaccine trials have involved a wide variety of candidates, and that the vaccines are free.

The survey also found that many people who hesitate would be open to certain incentives. With the country opening up and the return of work on the ground, the employer’s role in vaccination is becoming increasingly important. A quarter of those who hesitate and have a job said they would get the shot if their employer arranged for a workplace vaccination. Almost as many would agree if their employers gave them financial incentives between $ 50 and $ 200.

Overall, the strong growth in adults who have either received a dose of the vaccine or who are inclined to receive it is most likely due to their increased familiarity with the term. Surveys show that as they get to know more friends and relatives who got the shot, it is easier for them to imagine getting it themselves.

Categories
Health

Bloomberg Staff Get Entry to Hospital’s Vaccine Slots

Bloomberg Employees Get Access to Hospital’s Vaccine Slots

NYU Langone Health, a major New York City hospital system, has put aside Covid-19 vaccination shots for employees of Bloomberg LP, billionaire Michael R. Bloomberg’s financial data and media company.

Bloomberg employees were informed of the agreement in an internal memo on February 16. On Tuesday, when adults aged 30 and over were eligible for vaccination in New York, Bloomberg Human Resources Director Ken Cooper sent a second email to employees on the subject with the subject “* URGENT * Covid-19 Vaccines in New York”.

“NYU Langone has informed us that they are able to provide limited quantities of vaccines to Bloomberg employees who meet the approval requirements on a weekly basis,” Cooper wrote in the email received from the New York Times.

In the email on Tuesday, employees were informed that they would be sent registration instructions after filing a ticket in the company’s financial terminal system. The memo added that only Bloomberg employees were eligible under the plan, not their loved ones.

“Given the complexity of vaccine delivery and distribution, we continue to encourage you to do whatever you can to make an appointment yourself if you are eligible to receive the vaccine,” the email said. “You may find these appointments come in sooner than those made available through NYU.”

A Bloomberg spokesman declined to comment.

Mr Bloomberg has donated billions of dollars to the environment, education, public health, and other causes, including more than $ 3 billion in gifts to his alma mater, Johns Hopkins University.

His philanthropic arm has given New York University at least two gifts. The university’s Robert F. Wagner Graduate School of Public Service announced on March 2 that it would receive a $ 25 million donation from Bloomberg Philanthropies. The gift was made for a scholarship on behalf of Mr. Bloomberg’s daughter Georgina and his mother Charlotte. In 2017, Mr Bloomberg’s philanthropic arm donated nearly $ 6 million to set up an environmental law center at New York University School of Law.

NYU Langone Health has “formal corporate partnerships with organizations, school districts and communities that we are the preferred providers offering corporate wellness programs and facilitating access to our services,” a hospital system spokeswoman said in a statement. “Through this partnership, we have helped secure vaccines for Bloomberg employees, who are our patients, in accordance with New York State guidelines.”

“Philanthropy is not tied to NYU Langone’s vaccination programs,” added the spokeswoman. Commenting on Mr. Bloomberg’s March 2 donation, she said, “It is important to note that the gift went to NYU’s Wagner Graduate School. It wasn’t done to NYU Langone Health or NYU Grossman School of Medicine. It was completely independent of our institution. “

New York residents over 30 qualified for the vaccine Tuesday, resulting in a rush to book appointments.

Mr Bloomberg has told his staff that he expects them to return to the office after vaccination. “As soon as vaccines are available, we expect people to use the security they provide and return to the office,” he wrote in a February 2 memo reported by Business Insider. “Any questions? I’m at my desk.”

Categories
Health

Vaccine passports may show to be a privateness minefield

Singapore Airlines, Qantas shares jump

Crew members and travelers of Singapore Airlines in the transit hall of Changi Airport in Singapore on January 14, 2021.

Facebook Facebook Logo Log in to Facebook to connect with Roslan Rahman AFP | Getty Images

When the EU announced its plans for a “digital green certificate” this month, the tourism industry breathed a sigh of relief that perhaps the summer could be saved.

Since the outbreak of the coronavirus pandemic, the concept of a “vaccination pass” has been regularly put into circulation. Once vaccinated against Covid-19, a person could carry proof of vaccination that would allow them to travel or access services that are otherwise closed under lockdown.

The EU certificate, which avoids the use of the term “passport”, would create a common digital system for Europe, probably in the form of a smartphone app, to prove vaccination, negative test or recovery of the virus.

EU Justice Commissioner Didier Reynders said a common EU-wide approach to such a certificate would “gradually restore freedom of movement in the region”.

“It is also an opportunity to influence global standards and lead by example based on our European values ​​such as data protection,” he said earlier this month.

Various industries around the world have been tinkering with these passes for months.

IBM is working with New York State on a digital health passport that uses blockchain technology to verify a person’s test or vaccine IDs. Walmart, who is shooting in its stores, recently backed the demand for vaccine certificates.

Apple and Google previously worked together to create standards for contact tracking in smartphones. The EU has suggested that the tech giants could once again partner with the World Health Organization in this effort, but WHO has since denied it.

Now that the adoption of vaccines is accelerating, the prospect of these digital passports or certificates has caught the attention of many different industries.

Data privacy

The aviation and tourism industries – both brutalized last year – were most likely to be interested in using this technology to reopen global travel.

The International Air Transport Association launched their “Travel Pass” late last year and started a test with Singapore Airlines this month.

According to Katherine Kaczynska, deputy director of corporate communications at IATA, the app was originally developed to provide evidence of a negative test. It will be expanded to include proof of vaccination.

Kaczynska added that IATA is not in favor of requiring vaccines for travel, but that the industry group is instead viewing the app as a way to open up international travel.

Ultimately, the system will be integrated into an airline’s app, but it needs to be coherent in how various vaccination passport proposals are launched and operated, Kaczynska told CNBC.

Vaccination records electronically store medical information that is displayed as a QR code.

da-kuk | E + | Getty Images

“We’re working closely with governments because we need to make sure things are interoperable,” she said.

“It is the governments that have to come up with a standard for digital vaccine certificates, and then we have to make sure that it works with the IATA Travel Pass and other apps. Ours are specifically designed for aviation, but for it to work there.” obviously there has to be interoperability between different standards. ”

In view of the sensitive health-related data, the launch of a digital service raises questions about privacy and data protection.

IATA works with Evernym, a blockchain company that has worked on various projects for digital decentralized identities, including a project with the Red Cross.

“The main thing about the IATA Travel Pass is that it is a decentralized technology, which basically means that not all data is stored in any way in a central database. All data is stored on the passenger’s phone,” said Kaczynska .

According to the European Commission, the EU executive, only “essential information” will be required for the proposed system. This includes vaccination or test data and a unique identifier for the certificate.

ethics

Nicole Hassoun, a professor at Binghamton University who specializes in public health ethics, said that providing any type of vaccination record on a large scale requires careful consideration.

With vaccines being distributed in a patchwork of demographics, passports or certificates need to allow for exceptions to avoid discriminating against those who have not yet been vaccinated or who have health reasons for not being vaccinated, she said.

“Maybe you would allow some sort of passport system, but then there have to be health exemptions. There have to be exemptions for the welfare of people who have really good reasons to access these services (e.g. travel),” Hassoun told CNBC .

This is partly why the EU proposal not only focuses on vaccination but also includes negative tests.

A particular concern is that vaccines are still very new. While data from countries like Israel look promising, more data is needed to review how effective the various vaccines are in reducing transmission and what long-term immunity will look like, Hassoun added.

“We need more data on the effects on transmission for people who have been vaccinated or those with natural immunity. How long will it take? What if there are new strains?” She said.

“We have to be careful of what the private sector is doing and what governments are doing, and making sure we regulate when we have to, and making sure they are fair to everyone.”

She warned that the provision of passports and certificates must be fair, as is currently not the case with the introduction of vaccines themselves. As western nations like the UK and the US advance, others are lagging behind, such as Brazil, which has suffered some of the worst outbreaks in the world and is grappling with its introduction.

For the EU, which is facing its own supply problems due to disputes with AstraZeneca, the clock is ticking to have the digital green certificate ready for the summer season.

The framework requires swift examination and adoption by the European Parliament and the Council if Europe and its tourism sector are to avoid a second lost summer.

Categories
Business

It is ‘harmful’ if the EU experiments with vaccine nationalism: Analyst

Europe's suspension of AstraZeneca's Covid vaccine is damaging

The European Union could open a “Pandora’s Box” if it decides to restrict exports of coronavirus vaccines, a political analyst told CNBC last week.

Vaccinations in the 27-person block were hampered by production problems. Anglo-Swedish company AstraZeneca lowered its target for the first quarter from 90 million cans to 30 million cans earlier this year.

The shot, developed in collaboration with Oxford University, is preferred for the launch of vaccines in the European Union.

Officials have already imposed strict rules on export. The EU will check whether the receiving country has the virus under better control than Europe and whether there are any restrictions on vaccines or raw materials before allowing the shots to be sent.

However, some EU countries have concerns about the new rules and want the supply chains to remain open.

There is tremendous political pressure … to experiment with some kind of vaccine nationalism.

James Crabtree

Associate professor in practice

European Commission President Ursula von der Leyen “is really fighting” because other rich countries are doing much better than the EU on vaccinations, said James Crabtree, an associate professor at the Lee Kuan Yew School of Public Policy.

“There is tremendous political pressure … to experiment with some kind of vaccine nationalism,” Crabtree told CNBC’s Street Signs Asia on Friday.

“This is of course very dangerous as the EU is usually one of the most responsible international actors,” he said.

‘Pandora’s Box’

He also warned that other countries could follow the EU’s lead in prioritizing vaccines for local populations.

“When it tries to restrict the flow of vaccine from EU factories, it opens a Pandora’s box where countries like India may begin to do the same,” Crabtree said.

That could be very harmful as new variants of Covid are likely to keep popping up, he added.

EU trade chief Valdis Dombrovskis said it was “highly unfair” to accuse the EU of vaccine nationalism because it is “one of the largest vaccine exporters”.

Data shows that since December the EU has exported 77 million cans of the shots to 33 countries, while 88 million have been shipped to EU countries.

The bloc has also complained that London lacks the same level of reciprocity in the distribution of vaccines.

Heather Conley of the Center for Strategic and International Studies (CSIS) noted that the UK and the EU are working towards a “mutually beneficial relationship”.

Still, leaders in Europe are nervous about their political futures as some countries vote in the coming year or so, said Conley, director of the Europe, Russia and Eurasia program at CSIS.

“The political anger of the heads of state and government and this hysteria about the political future will lead the EU to take action that could ultimately counter its long-term interest in embracing these vaccines very quickly,” she told Friday CNBC’s “Squawk Box Asia”.

“I think the international damage this would do to global vaccine production would be greater than the increased number of vaccines in the EU,” she said.

A doctor administers the Astrazeneca vaccine at a mass coronavirus (COVID-19) drive-through clinic in Milan, Italy on March 15, 2021.

Anadolu Agency | Anadolu Agency | Getty Images

Categories
Health

Compensation for victims of Covid vaccine accidents is restricted

Compensation for victims of Covid vaccine injuries is limited

Joanna Oakley got her annual flu shot in 2015 and immediately knew something was wrong.

“It felt like it hit the bone right away. And over the next few days I noticed that it was getting increasingly sore and it got where I couldn’t move my arm, I couldn’t turn my steering wheel in my car . ” She said.

As a nurse, Oakley is trained to give injections.

“It wasn’t until it happened to me that I started researching. I found that it actually happened more often than I would ever imagine,” she said.

Nurse Joanna Oakley and her son.

Source: Joanna Oakley

Oakley says she had three surgeries and that her arm never returned to normal. She suffered a so-called shoulder injury related to vaccine administration, or SIRVA.

“As a mother and wife and as a nurse, I was more concerned about what this injury would do to me, as far as I know, could I get it repaired? Would I be normal again?” She said.

Oakley is not alone. SIRVA is the most common vaccination violation for which people seek government compensation.

Twenty-one people have filed claims for adverse reactions to Covid-19 shots in the Countermeasures Injury Compensation Program. This emerges from a response to the Department of Health and Human Services Freedom of Information Act to Professor Peter Meyers of the George Washington Law School.

To date, there have been seven reports of shoulder injuries from Covid-19 bullets as per the Vaccine Adverse Event Reporting System, which is maintained by the Centers for Disease Control of Prevention and does not review the reports. However, none of the 21 Covid-19 vaccine claims submitted to the compensation program are related to shoulder injuries, according to FOIA records.

Joanna Oakley suffered a serious shoulder injury from a flu vaccine.

Source: Joanna Oakley

“I have represented many clients whose lives have been changed by an unfortunate side effect of vaccination. It happens. It is rare, but it does. And often they are on the verge of the end of their life,” said attorney Altom Maglio.

The Countermeasure Compensation Program provides “compensation for those injured or dying of a vaccination, drug, device, or other so-called countermeasure necessary to prevent, treat, or combat a pandemic, epidemic, or security threat,” it says on the program website.

On March 10, 2020, then Secretary of Health and Human Services, Alex Azar, made a statement under the Public Preparedness and Emergency Preparedness Act approving this program for Covid-related claims.

HHS has a far more generous program known as the National Vaccine Injury Compensation Program. Currently, injuries are treated by 16 commonly used vaccines such as the flu, whooping cough and polio, but the Covid vaccine is not because it is not yet approved for use in children.

The countermeasure compensation program rarely pays off and rejects more than 90% of submitted claims according to HHS and FOIA records. In this case, claims averaging $ 200,000, according to HHS – about 60% less than the average National Vaccine Injury Compensation Program payment. Since the program was launched in 2009, only 29 applications for the H1N1 and smallpox vaccines have been paid in August. One of these has been classified as shoulder pain by HHS.

Maglio calls the CICP a “black hole”.

“Really, it’s a compensation program in name only and not in reality,” he said.

The VICP offers victims the opportunity to sue in court with judges and lawyers and to have the right to appeal. Among the other, he said, there is no right of appeal.

Unlike the VICP, the CICP does not cover legal fees or pain and suffering.

The VICP has paid approximately $ 4.5 billion in total compensation as of March 1 since filing claims in 1998. According to HHS, this dwarfs the approximately $ 6 million in paid services of the CICP over the life of the program.

In July last year, HHS proposed a new regulation aimed at reversing existing consumer protection for shoulder injuries caused by vaccination shots. These were caused by “negligence of the vaccine administrator” rather than the vaccines themselves. That would have forced people with shoulder injuries to sue whoever gave the vaccine, Maglio said.

It was supposed to go into effect in February, but the new administration under President Joe Biden has halted all of the rules proposed in the final days of the Trump administration.

The Biden government last week announced plans to withdraw the final settlement.

“HHS is also proposing to repeal the final rule amid fears it could negatively impact vaccine administrators, which goes against the federal government’s efforts to increase vaccinations in the US to address coronavirus disease 2019 to respond to (COVID-19) pandemic, “HHS wrote in its notice to withdraw the proposed rules.

A spokesman for Health Resources and Service Administration, the agency within HHS that oversees vaccination injury compensation programs, declined to be interviewed. Instead, the CNBC agency referred to its public notices.

“I believe instead of weakening this program and removing injuries from it, it needs to be strengthened,” said Rep. Lloyd Doggett, D-Texas. “It hasn’t really been revised since 1988 when it came into effect.”

Rep. Lloyd Doggett (D-TX) speaks on lower drug prices, particularly those related to coronavirus, during a press conference on Capitol Hill March 5, 2020 in Washington, DC.

Samuel Corum | Getty Images

Doggett’s office estimates that 5,000 to 6,000 people across the country are likely to have an adverse reaction to the Covid vaccine, based on statistics from the H1N1 vaccine.

“It will build confidence to know that in the extremely unlikely event that there is a probability of 1 in a million that you will face adverse consequences that there is a fund to protect you so that you do not have to deal with huge medical bills and others Losses are charged. ” ” he said.

Oakley said she believed in vaccines but wanted a program in case things go wrong.

“I would only be concerned if someone took this program away, if someone had a problem, an adverse effect from a vaccine, they really would have no recourse,” she said.